Hours of acute ischemic stroke. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Brain Middle Cerebral Artery Cerebral Arteries Carotid Artery, Internal Blood-Brain Barrier Carotid Arteries Basilar Artery Posterior Cerebral Artery Cerebral Cortex

Diseases54

Stroke Brain Ischemia Acute Disease Cerebral Hemorrhage Cerebrovascular Disorders Cerebral Infarction Intracranial Thrombosis Intracranial Hemorrhages Infarction, Middle Cerebral Artery Ischemic Attack, Transient Brain Infarction Intracranial Embolism Intracranial Arterial Diseases Brain Edema Infarction, Anterior Cerebral Artery Intracranial Arteriosclerosis Ischemia Recurrence Atrial Fibrillation Cerebral Arterial Diseases Carotid Stenosis Intracranial Embolism and Thrombosis Vertebrobasilar Insufficiency Embolism Carotid Artery Thrombosis Hemorrhage Infarction, Posterior Cerebral Artery Brain Damage, Chronic Arterial Occlusive Diseases Carotid Artery Diseases Nervous System Diseases Hypertension Phlebitis Stroke, Lacunar Thromboembolism Disease Models, Animal Leukoaraiosis Paresis Disease Progression Deglutition Disorders Yin Deficiency Thrombophilia Thrombosis Myocardial Infarction Reperfusion Injury Fever Hyperglycemia Remission, Spontaneous Hemiplegia Genetic Predisposition to Disease Vascular Diseases Diabetes Mellitus Aphasia Venous Thrombosis

Chemicals and Drugs41

Fibrinolytic Agents Tissue Plasminogen Activator Neuroprotective Agents Anticoagulants Heparinoids Platelet Aggregation Inhibitors Plasminogen Activators Biological Markers Aspirin Nadroparin Pregnatrienes Ancrod Placebos Pipecolic Acids Recombinant Proteins Urokinase-Type Plasminogen Activator S100 Calcium Binding Protein beta Subunit Warfarin Heparin Levallorphan Cytidine Diphosphate Choline Aspartate Aminotransferase, Cytoplasmic Fibrin Fibrinogen Degradation Products Heparin, Low-Molecular-Weight Benzenesulfonates Contrast Media C-Reactive Protein Hydroxymethylglutaryl-CoA Reductase Inhibitors Minocycline Technetium Tc 99m Exametazime Phosphopyruvate Hydratase Cyclic Nucleotide Phosphodiesterases, Type 3 Ticlopidine Nimodipine Organotechnetium Compounds Fibrinogen Matrix Metalloproteinase 9 Practolol Cyclic Nucleotide Phosphodiesterases, Type 4 Antihypertensive Agents S100 Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment103

Thrombolytic Therapy Mechanical Thrombolysis Treatment Outcome Thrombectomy Tomography, X-Ray Computed Reperfusion Cerebral Revascularization Risk Factors Cerebral Angiography Prospective Studies Severity of Illness Index Injections, Intra-Arterial Predictive Value of Tests Retrospective Studies Magnetic Resonance Imaging Diffusion Magnetic Resonance Imaging Infusions, Intra-Arterial Follow-Up Studies Injections, Intravenous Magnetic Resonance Angiography Cohort Studies Infusions, Intravenous Embolectomy Ultrasonography, Doppler, Transcranial Perfusion Imaging Registries Odds Ratio Prognosis Double-Blind Method Neurologic Examination Endovascular Procedures Administration, Intravenous Multivariate Analysis Case-Control Studies Incidence Logistic Models Randomized Controlled Trials as Topic Risk Hemodilution Regression Analysis Pilot Projects Risk Assessment Transportation of Patients Multicenter Studies as Topic Reproducibility of Results Placebos Clinical Trials as Topic Sensitivity and Specificity Disability Evaluation Hospitalization Emergency Treatment Feasibility Studies Echo-Planar Imaging Ultrasonic Therapy Patient Selection Vascular Access Devices Proportional Hazards Models Blood Pressure Disease Models, Animal Hypothermia, Induced Stents Single-Blind Method Patient Discharge Endarterectomy, Carotid Angiography, Digital Subtraction Echocardiography, Transesophageal Activities of Daily Living Controlled Clinical Trials as Topic Survival Rate Drug Therapy, Combination Endpoint Determination Statistics, Nonparametric Drug Administration Schedule Hospital Mortality Body Temperature Prevalence Blood Flow Velocity Stroke Volume Angioplasty Survival Analysis Length of Stay Hyperbaric Oxygenation Bloodletting Data Interpretation, Statistical Observer Variation Models, Statistical Image Enhancement Monitoring, Physiologic Tomography, Emission-Computed, Single-Photon Analysis of Variance Clinical Trials, Phase III as Topic Hematocrit ROC Curve Angiography Catheterization Kaplan-Meier Estimate Treatment Failure Clinical Protocols Chi-Square Distribution Medicine, Chinese Traditional Suction Patient Admission Combined Modality Therapy

Phenomena and Processes21

Time Factors Cerebrovascular Circulation Recovery of Function Odds Ratio Risk Sensitivity and Specificity Blood Pressure Blood Volume Collateral Circulation Dose-Response Relationship, Drug Hemostasis Body Temperature Blood Flow Velocity Stroke Volume Diffusion Hematocrit Fibrinolysis Remission, Spontaneous Genetic Predisposition to Disease Chi-Square Distribution Platelet Activation

Disciplines and Occupations2

Neurology Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena7

National Institutes of Health (U.S.)Activities of Daily Living Demography Sex Distribution Medicine, Chinese Traditional Age Distribution National Institute of Neurological Disorders and Stroke

Information Science9

Registries Incidence Databases, Factual Image Processing, Computer-Assisted Survival Rate Hospital Mortality Prevalence Data Interpretation, Statistical Image Enhancement

Named Groups4

Asian Continental Ancestry Group European Continental Ancestry Group African Continental Ancestry Group Inpatients

Health Care71

Treatment Outcome Risk Factors Prospective Studies Severity of Illness Index Predictive Value of Tests Retrospective Studies Follow-Up Studies Cohort Studies Registries Emergency Medical Services Odds Ratio Double-Blind Method Comorbidity Multivariate Analysis Case-Control Studies Incidence Logistic Models Age Factors Randomized Controlled Trials as Topic Risk Regression Analysis Outcome Assessment (Health Care)Pilot Projects Risk Assessment Transportation of Patients Multicenter Studies as Topic Reproducibility of Results Safety Clinical Trials as Topic National Institutes of Health (U.S.)Sensitivity and Specificity Hospitalization Feasibility Studies Sex Factors Patient Selection Proportional Hazards Models Hospital Units American Heart Association Causality Single-Blind Method Patient Discharge Activities of Daily Living Controlled Clinical Trials as Topic Survival Rate Hospitals Statistics, Nonparametric Hospital Mortality Prevalence Demography Survival Analysis Length of Stay Data Interpretation, Statistical Hospitals, Rural Observer Variation Models, Statistical Secondary Prevention Guideline Adherence Analysis of Variance Clinical Trials, Phase III as Topic ROC Curve Emergency Service, Hospital Kaplan-Meier Estimate Treatment Failure Clinical Protocols Sex Distribution Chi-Square Distribution Age Distribution Outcome and Process Assessment (Health Care)Practice Guidelines as Topic Patient Admission National Institute of Neurological Disorders and Stroke

Geographicals8

United States Kentucky China Ohio Germany Japan Canada Georgia

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Stroke Brain Ischemia Fibrinolytic Agents Tissue Plasminogen Activator Acute Disease Thrombolytic Therapy Cerebral Hemorrhage Cerebrovascular Disorders Cerebral Infarction Intracranial Thrombosis Mechanical Thrombolysis Intracranial Hemorrhages Infarction, Middle Cerebral Artery Treatment Outcome Thrombectomy Ischemic Attack, Transient Time Factors Tomography, X-Ray Computed Reperfusion Cerebral Revascularization Risk Factors Cerebral Angiography Prospective Studies Brain Infarction Intracranial Embolism Severity of Illness Index Injections, Intra-Arterial Predictive Value of Tests Retrospective Studies Neuroprotective Agents Magnetic Resonance Imaging Diffusion Magnetic Resonance Imaging Infusions, Intra-Arterial Cerebrovascular Circulation Follow-Up Studies Injections, Intravenous Magnetic Resonance Angiography Intracranial Arterial Diseases Cohort Studies Brain Recovery of Function Infusions, Intravenous Anticoagulants Embolectomy Middle Cerebral Artery Cerebral Arteries Ultrasonography, Doppler, Transcranial Perfusion Imaging Heparinoids Registries Emergency Medical Services Odds Ratio Platelet Aggregation Inhibitors Prognosis Brain Edema Double-Blind Method Infarction, Anterior Cerebral Artery Neurologic Examination Endovascular Procedures Intracranial Arteriosclerosis Administration, Intravenous Plasminogen Activators Comorbidity Ischemia Recurrence Multivariate Analysis Case-Control Studies Atrial Fibrillation Incidence Logistic Models Age Factors Randomized Controlled Trials as Topic Cerebral Arterial Diseases Risk Biological Markers Aspirin Nadroparin Carotid Stenosis Hemodilution Neurology Regression Analysis Outcome Assessment (Health Care)Intracranial Embolism and Thrombosis Vertebrobasilar Insufficiency Pregnatrienes Pilot Projects Embolism Databases, Factual Risk Assessment Transportation of Patients Carotid Artery Thrombosis Multicenter Studies as Topic United States Ancrod Reproducibility of Results Safety Placebos Clinical Trials as Topic Hemorrhage National Institutes of Health (U.S.)

No FAQ available that match "hours of acute ischemic stroke"